All treatments
Treatment
Locametz 25 micrograms kit for radiopharmaceutical preparation clinical trials
2 indexed studies · 0 currently recruiting
- Ongoing, recruitingTherapeutic exploratory (Phase II)
Diagnostic Performance of Prostate Specific Membrane Antigen (PSMA) Positron Emission Tomography/Computed Tomography (PET/CT) Imaging for Pre-operative Lymph Node Assessment in Intermediate and High-risk Nonmetastasic Prostate Cancer
This study looks at a special type of scan called a PET-PSMA scan to see how well it finds cancer in lymph nodes for men with prostate cancer. It helps doctors decide the best treatment, especially before surgery.
For: Prostate CancerFrance - AuthorisedTherapeutic confirmatory (Phase III)
PSMA PET For intermediate- or high-risk prostate cancer prior to RadioTherapY: A prospective interventional randomized clinical trial (P4RTY)
This study looks at a special scan called PSMA PET for men with prostate cancer before radiotherapy. It aims to see if this scan helps manage their cancer better and improves their health over time compared to standard care.
For: Prostate cancerGermany